Adamis Pharmaceuticals Corporation Interest Expense | ADMP

Interest expense is the amount of interest a company is obligated to pay to creditors for using debt financing (bank loans, bonds, leasing, etc.) during the reporting period.

Includes:

Interest on bank loans
Interest on corporate bonds
Interest on leases
Interest on credit lines and overdrafts

High interest expenses indicate a high debt burden — the company may be vulnerable to rising rates or declining revenue.

Low interest expenses with high profits are a sign of financial stability.

Annual Interest Expense Adamis Pharmaceuticals Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
-	6.65 K	4.92 K	123 K	158 K	231 K	214 K	-	226 K	8.48 M	35.4 K	744 K	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
8.48 M	4.92 K	1.02 M

Quarterly Interest Expense Adamis Pharmaceuticals Corporation

2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
29.5 K	46.3 K	-113 K	-	1.86 K	2.9 K	1.88 K	-	1.86 K	44.9 K	39.3 K	-	46 K	32.9 K	38.3 K	-	21.9 K	23 K	24 K	-	30.7 K	51.4 K	50.7 K	-	52.6 K	59.4 K	67.5 K	-	70.2 K	72.4 K	-	-	371 K	226 K	145 K	-	371 K	226 K	226 K	5.3 M	5.3 M	2.78 M	405 K	845 K	845 K	579 K	295 K	2.61 K	2.61 K	2.55 K	27.5 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
5.3 M	-113 K	455 K

Interest Expense of other stocks in the Drug manufacturers industry

Issuer	Interest Expense	Price	% 24h	Market Cap	Country
Solid Biosciences SLDB	824 K	$ 9.93	1.31 %	$ 869 M	USA
Sonoma Pharmaceuticals SNOA	16 K	$ 1.33	0.38 %	$ 2.24 M	USA
TherapeuticsMD TXMD	300 K	$ 2.14	0.22 %	$ 24.8 M	USA
Veru VERU	768 K	$ 2.58	0.39 %	$ 37.8 M	USA
Viatris VTRS	471 M	$ 16.61	0.03 %	$ 19.1 B	USA
Agile Therapeutics AGRX	1.42 M	-	10.11 %	$ 58.2 M	USA
Alimera Sciences ALIM	10.2 M	-	-	$ 142 M	USA
Catalent CTLT	-4 M	-	-	$ 11.5 B	USA
DURECT Corporation DRRX	2.4 M	-	-	$ 50.1 M	USA
Eagle Pharmaceuticals EGRX	4.04 M	-	-39.89 %	$ 27.7 M	USA
Lannett Company LCI	58 M	-	1.15 %	$ 7.11 M	USA
OptiNose OPTN	19.5 M	-	-	$ 1.08 B	USA
PetIQ PETQ	38.3 M	-	1.64 %	$ 400 M	USA
Radius Health RDUS	18.3 M	-	-	$ 1.42 B	USA
Recro Pharma REPH	9.96 M	-	-4.76 %	$ 65.3 M	USA
Emergent BioSolutions EBS	54.2 M	$ 6.0	0.08 %	$ 321 M	USA
Endo International plc ENDP	350 M	-	-	$ 28.9 M	Irlanda
Relmada Therapeutics RLMD	5.15 M	$ 4.25	1.37 %	$ 168 M	USA
Bausch Health Companies BHC	-142 M	$ 6.43	0.31 %	$ 2.38 B	Canada
HEXO Corp. HEXO	20.1 M	-	2.45 %	$ 38.1 M	Canada
Athenex ATNX	25.8 M	-	-23.39 %	$ 1.76 M	USA
China Pharma Holdings CPHI	27.3 K	$ 0.84	2.56 %	$ 3.6 M	China
Cumberland Pharmaceuticals CPIX	496 K	$ 6.62	0.29 %	$ 98.3 M	USA
Cronos Group CRON	-241 K	$ 3.19	0.62 %	$ 1.22 B	Canada
Evolus EOLS	-539 K	$ 8.88	2.76 %	$ 572 M	USA
Harrow Health HROW	47 K	$ 37.85	0.73 %	$ 1.39 B	USA
Sundial Growers SNDL	81 K	$ 1.44	0.35 %	$ 372 M	Canada
Canopy Growth Corporation CGC	38.2 M	$ 0.97	1.73 %	$ 289 M	Canada
Organogenesis Holdings ORGO	-5 K	$ 1.6	4.27 %	$ 203 M	USA
Pacira BioSciences PCRX	-6.62 M	$ 25.87	0.08 %	$ 1.15 B	USA
Perrigo Company plc PRGO	-13.2 M	$ 14.58	4.56 %	$ 2.02 B	USA
Rockwell Medical RMTI	-623 K	$ 8.06	0.94 %	$ 290 M	USA
Aerie Pharmaceuticals AERI	-27.9 M	-	-	$ 754 M	USA
AcelRx Pharmaceuticals ACRX	134 K	-	7.5 %	$ 6.35 M	USA
Assertio Holdings ASRT	2.78 M	-	-	$ 150 M	USA
Avadel Pharmaceuticals plc AVDL	13 M	-	-	$ 2.06 B	France
Evoke Pharma EVOK	501 K	-	-	$ 36.6 M	USA
Jupiter Wellness JUPW	152 K	-	-	$ 33.6 M	USA
Neoleukin Therapeutics NLTX	12 K	-	-	$ 193 M	Canada
ProPhase Labs PRPH	-174 K	-	-	$ 5.07 M	USA
SCYNEXIS SCYX	3.13 M	$ 5.15	0.75 %	$ 257 M	USA
Tricida TCDA	17.6 M	-	-	$ 3.25 M	USA
Tilray TLRY	41.3 M	$ 4.3	0.22 %	$ 3.83 B	Canada
cbdMD YCBD	34.3 K	$ 0.5	5.07 %	$ 2.01 M	USA
Zomedica Corp. ZOM	-144 K	-	-0.21 %	$ 98 M	USA